Vesta Freight Drives 18x Shipment Growth with Descartes’ Transportation Management Solution Suite 
Anson Resources to Commence Drilling at Yellow Cat Uranium-Vanadium Project, Utah USA 
Anzé Mofor Launches Love Better: A Sacred Journey Back to You, A Powerful Guide to Reclaiming Self-Love and Transforming Relationships 
Voghion Reveals A Year Of Global Shopping Events BioCardia Reports Second Quarter 2023 Business Highlights and Financial Results
SUNNYVALE, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular…
Surrozen Provides Second Quarter 2023 Financial Results
SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers…
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
2Q2023 Total Revenues of $60.1 Million, a 77% Y-o-Y Increase 2Q2023 Adjusted EBITDA(1) of $6.4…
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
– Dutch Ministry of Health Approves VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce the Risk of…
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
– Key Catalysts ahead with Multiple Value Generating Readouts-– Expects to Release Phase 1/2 Data…
Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates
Herpesvirus candidate ABI-5366 anticipated to enter clinic in first half of 2024 New data for…
Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
FDA indicated that approval of MAT2203 as a first-line treatment for invasive aspergillosis will require…
4D Molecular Therapeutics Reports Second Quarter 2023 Financial Results and Operational Highlights
Presented positive interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial for patients with…
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (“Acasti” or…
TELA Bio Reports Second Quarter 2023 Financial Results
MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage…
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Initiation of Phase 2b BEACON-IPF trial of bexotegrast in patients with IPF INTEGRIS-PSC Phase 2a…
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
Confirms Timing for Primary Outcome Data Readout for two Phase 2 OraGrowtH Trials in Q4…
89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
– Published data from ENLIVEN Phase 2b trial of pegozafermin in NASH in The New…
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society (IMS) Annual…
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society (IMS) Annual…
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results
Advancing enrollment of TAMARACK Phase 2 study in metastatic castration-resistant prostate cancer (mCRPC) under revised…
Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test
NEWS RELEASE9 AUGUST 2023, 4PM ET / 22:00 CET Cigna Expands Commercial and…
aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis currently enrolling in the U.S., Europe…
Scott McCaffrey Takes Top Job as Head of Momentum Independent Network
DALLAS–(BUSINESS WIRE)–Momentum Independent Network Inc. (MIN), an affiliate of Hilltop Securities Inc. (HilltopSecurities), is pleased…
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines…